Health Care and Profits, a Poor Mix / NY Times
An excellent piece discusses how turning over aspects of healthcare to private industry led to greater costs without accompanying benefits, and compares the US with other first world countries.
Similar Posts
Dr. Jesse Goodman (Deputy FDA Commissioner)’s December 2, 2008 slides note adjuvant safety questionable
On December 2-3, 2008, FDA with joint NIAID sponsorship held a public workshop “for academics, government researchers, government regulators, vaccine clinical trial experts and industry representatives. The purpose of this workshop is to assess the scientific knowledge base regarding vaccine adjuvants and to facilitate the development of a research agenda to improve the safety and…
Moderna recalls 765,000 COVID vaccine doses in Europe/ Reuters
https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-recalls-thousands-covid-vaccine-doses-2022-04-08/ April 8 (Reuters) – Moderna Inc (MRNA.O) said on Friday it was recalling 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi (ROVI.MC) after a vial was found contaminated by a foreign body. No safety issues have been identified, Moderna said about the lots that were distributed in Norway, Poland, Portugal, Spain and Sweden in…
Newest Emergent BioSolutions excuse on its Covid vaccine delay
This article does not make sense to me, but I am reproducing tonight’s NYT story below. If the quality control issues are still being sorted out, then the “conflation” of two vaccine ingredients is not the whole story of the plant’s problems. FDA knew there were problems a month ago, when it withheld the EUA…
FDA VRBPAC meeting coming on June 10 regarding pediatric Covid vaccines. How FDA controls its “advisors”
1. FDA requires written submissions and signups for oral submissions before it posts the agenda and the actual issues to be presented to its advisory committee. How can you formulate a comment for the advisory committee when you do not know what it is being asked to consider? Thus the ability to make relevant public…
200 Escapes of pathogens from high-containment labs in the US, YEARLY
SARS-CoV (the first SARS virus) and its cousin SARS-CoV-2 (the virus causing our current pandemic) are classified by the US government as Select Agents, organisms that pose a significant threat to humans, and could be used for bioterrorism. The current Select Agent program came into being after the 2001 anthrax letters event. The Department of Health…